Cell Bio-Systems Completes Prototype Design of Super Luer Tissue Transfer Device.SAN DIEGO -- Cell Bio-Systems, Inc. (Pink Sheets:CBSI CBSI CUNA Brokerage Services, Inc. CBSI Cambodian Buddhist Society, Inc. (Silver Springs, Maryland) CBSI Certified Bridge Safety Inspector CBSI Custom Business Solutions, Inc. ), a biotechnology company positioned to manufacture and distribute patented, disposable technologies for cosmetic surgery cosmetic surgery, plastic surgery for cosmetic purposes, such as the improvement of the appearance of the face by removing wrinkles or reshaping the nose. and other living tissue procedures, announced today that it has completed the prototype design for a device that allows tissue to be transferred from one syringe to another. The design incorporates the company's patented flagship instrument, the Super Luer injector; and according to Marc Pilkington, Cell Bio-Systems President and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. , the company is applying for an additional patent on the new device. "This device is essential for fat transfer procedures Transfer Procedures The procedure by which ownership of a stock moves from one party to another. The transfer agent follows a detailed, documented series of steps governed by the SEC to ensure that a transaction has been completed. because it facilitates the safe transfer of tissue from one storage device to another, usually from a larger sized syringe to a smaller, 1cc syringe," said Pilkington. "It is a key component in our Living Tissue Management(TM) System, and can be adapted for numerous, future applications including cell therapies and stem cell stem cell In living organisms, an undifferentiated cell that can produce other cells that eventually make up specialized tissues and organs. There are two major types of stem cells, embryonic and adult. research." To successfully execute a fat transfer procedure, fat tissue is typically harvested utilizing a stainless steel stainless steel: see steel. stainless steel Any of a family of alloy steels usually containing 10–30% chromium. The presence of chromium, together with low carbon content, gives remarkable resistance to corrosion and heat. , tubular device - called a cannula cannula /can·nu·la/ (kan´u-lah) a tube for insertion into a vessel, duct, or cavity; during insertion its lumen is usually occupied by a trocar. can·nu·la or can·u·la n. pl. - that is attached to a syringe. Once tissue is harvested, it must be prepared and transferred to smaller syringes with minimal damage to living cells and without fear of contamination. The Super Luer to Super Luer transfer utilizes disposable technology that allows tissue to be manipulated from one syringe to another in the safest, least traumatic means possible. Though re-sterilized, steel cannulas are reused in hundreds of procedures, typically for as long as two years or more. Despite safety concerns and complications regularly ascribed to steel cannulas, no comparable, disposable device currently exists. About Cell Bio-Systems Based in San Diego, California “San Diego” redirects here. For other uses, see San Diego (disambiguation). San Diego is a coastal Southern California city located in the southwestern corner of the continental United States. As of 2006, the city has a population of 1,256,951. , Cell Bio-Systems is the exclusive licensee of two patented syringe connection products that it plans to adapt as disposable devices for liposuction Liposuction Definition Liposuction, also known as lipoplasty or suction-assisted lipectomy, is cosmetic surgery performed to remove unwanted deposits of fat from under the skin. and other Living Tissue Management(TM) procedures. The company is developing an affordable, disposable product line that will fill this void in the cosmetic surgery and living tissue marketplace. The company's patented, groundbreaking technology will increase patient safety and enhance procedural outcomes. Most notably, Cell Bio-Systems devices can be adapted for a variety of procedures, ranging from fat transfers to biopsies to stem cell research. The company ultimately will develop a complete living tissue management system. CBSI shareholders are encouraged to visit http://www.cellbiosystems.com and to register on the "Investor Relations" page to receive ongoing CBSI news updates. Legal Notice Regarding Forward-Looking Statements: "Forward-looking statements'' as defined in the Private Securities Litigation Reform Act The Private Securities Litigation Reform Act of 1995 (PSLRA) implemented several significant substantive changes affecting certain cases brought under the federal securities laws, including changes related to pleading, discovery, liability, class representation and awards fees and of 1995 may be included in this news release. These statements relate to future events or our future financial performance. These statements are only predictions and may differ materially from actual future results or events. CBSI disclaims any intention or obligation to revise any forward-looking statements whether as a result of new information, future developments or otherwise. There are important risk factors that could cause actual results to differ from those contained in forward-looking statements, including, but not limited to risks associated with changes in general economic and business conditions (including in the information technology and financial information industry), actions of our competitors, the extent to which we are able to develop new services and markets for our services, the time and expense involved in such development activities, the level of demand and market acceptance of our services, and changes in our business strategies. |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion